FDA sends warning letter to Novo Nordisk over failure to report deaths, adverse side effects of GLP-1s
- Posted on March 10, 2026
- By The Hill
- 6 Views
FDA sends warning letter to Novo Nordisk over failure to report deaths, adverse side effects of GLP-1s
The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications…
